Product Corrective Action Letter Localization

An American biomedical device manufacturer found that their Language Service Provider's (LSP) response and turnaround times occasionally skirted the project deadlines and so was understandably concerned about the potential losses that could be incurred in the event of a missed FDA Form 483 deadline. With this in mind, the company contracted CSOFT Health Sciences.